Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeffrey M. Skell
Jeffrey M. Skell
Schering-Plough
Chemistry
Sildenafil
In vivo
Xanthine
Biochemistry
4
Papers
54
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Δ9-Tetrahydrocannabinolic acid A, the precursor to Δ9-tetrahydrocannabinol (THC)
2021
Acta Crystallographica Section C-crystal Structure Communications
Jeffrey M. Skell
Michael I. Kahn
Bruce M. Foxman
Show All
Source
Cite
Save
Citations (1)
Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED.
2005
Bioorganic & Medicinal Chemistry Letters
Craig D. Boyle
Ruo Xu
Theodros Asberom
Samuel Chackalamannil
John W. Clader
William J. Greenlee
Henry Guzik
Yuequing Hu
Zhiyong Hu
Claire M. Lankin
Dmitri A. Pissarnitski
Andrew Stamford
Yuguang Wang
Jeffrey M. Skell
Stanley Kurowski
Subbarao Vemulapalli
Jairam Palamanda
Madhu Chintala
Ping Wu
Joyce Myers
Peng Wang
Show All
Source
Cite
Save
Citations (24)
polymorphous forms of an inhibitor of xanthine phosphodiesterase v.
2003
Craig D. Boyle
Albert W. Buchholz
Vilas H. Dahanukar
Kevin Klopfer
Hoa N. Nguyen
Cecilia A. Orr
Jeffrey M. Skell
Ilia A. Zavialov
Fucheng Zhang
Show All
Source
Cite
Save
Citations (0)
Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors.
2002
Bioorganic & Medicinal Chemistry Letters
Yuguang Wang
Samuel Chackalamannil
Zhiyong Hu
Craig D. Boyle
Claire M. Lankin
Yan Xia
Ruo Xu
Theodros Asberom
Dmitri A. Pissarnitski
Andrew Stamford
William J. Greenlee
Jeffrey M. Skell
Stanley Kurowski
Subbarao Vemulapalli
Jairam Palamanda
Madhu Chintala
Ping Wu
Joyce Myers
Peng Wang
Show All
Source
Cite
Save
Citations (29)
1